Company Overview - Xiangsheng Medical's closing price on August 14 was 33.85 yuan, down 2.17%, with a rolling PE ratio of 27.79 times and a total market capitalization of 3.795 billion yuan [1] - The company specializes in the research, manufacturing, and sales of ultrasound medical imaging equipment, and has been recognized as a "Little Giant" enterprise for 2024 by the national government [1] Financial Performance - For Q1 2025, Xiangsheng Medical reported revenue of 128 million yuan, a year-on-year decrease of 9.16%, and a net profit of 41.6145 million yuan, down 8.62% year-on-year, with a gross profit margin of 61.33% [1] Shareholder Information - As of March 31, 2025, the number of shareholders for Xiangsheng Medical was 6,509, an increase of 1,499 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 55.76 times, with a median of 39.14 times, placing Xiangsheng Medical at the 55th position in the industry ranking [1][2] - The industry average market capitalization is 11.792 billion yuan, while the median is 5.679 billion yuan [2]
祥生医疗收盘下跌2.17%,滚动市盈率27.79倍,总市值37.95亿元